These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23785198)

  • 1. Retrovirus restriction by TRIM5 proteins requires recognition of only a small fraction of viral capsid subunits.
    Shi J; Friedman DB; Aiken C
    J Virol; 2013 Aug; 87(16):9271-8. PubMed ID: 23785198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
    Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM5 is an innate immune sensor for the retrovirus capsid lattice.
    Pertel T; Hausmann S; Morger D; Züger S; Guerra J; Lascano J; Reinhard C; Santoni FA; Uchil PD; Chatel L; Bisiaux A; Albert ML; Strambio-De-Castillia C; Mothes W; Pizzato M; Grütter MG; Luban J
    Nature; 2011 Apr; 472(7343):361-5. PubMed ID: 21512573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.
    Black LR; Aiken C
    J Virol; 2010 Jul; 84(13):6564-9. PubMed ID: 20410272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
    Carthagena L; Parise MC; Ringeard M; Chelbi-Alix MK; Hazan U; Nisole S
    Retrovirology; 2008 Jul; 5():59. PubMed ID: 18613956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
    Sastri J; Campbell EM
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.
    Grütter MG; Luban J
    Curr Opin Virol; 2012 Apr; 2(2):142-50. PubMed ID: 22482711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM5 acts as more than a retroviral restriction factor.
    de Silva S; Wu L
    Viruses; 2011 Jul; 3(7):1204-9. PubMed ID: 21866272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexagonal assembly of a restricting TRIM5alpha protein.
    Ganser-Pornillos BK; Chandrasekaran V; Pornillos O; Sodroski JG; Sundquist WI; Yeager M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):534-9. PubMed ID: 21187419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids.
    Li YL; Chandrasekaran V; Carter SD; Woodward CL; Christensen DE; Dryden KA; Pornillos O; Yeager M; Ganser-Pornillos BK; Jensen GJ; Sundquist WI
    Elife; 2016 Jun; 5():. PubMed ID: 27253068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
    Kutluay SB; Perez-Caballero D; Bieniasz PD
    PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid.
    Shi J; Aiken C
    Virology; 2006 Jul; 350(2):493-500. PubMed ID: 16624363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trivalent RING Assembly on Retroviral Capsids Activates TRIM5 Ubiquitination and Innate Immune Signaling.
    Fletcher AJ; Vaysburd M; Maslen S; Zeng J; Skehel JM; Towers GJ; James LC
    Cell Host Microbe; 2018 Dec; 24(6):761-775.e6. PubMed ID: 30503508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction of HIV-1 and other retroviruses by TRIM5.
    Ganser-Pornillos BK; Pornillos O
    Nat Rev Microbiol; 2019 Sep; 17(9):546-556. PubMed ID: 31312031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
    Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
    PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
    Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
    J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
    Berthoux L; Sebastian S; Sayah DM; Luban J
    J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+ T Cells.
    Jimenez-Moyano E; Ruiz A; Kløverpris HN; Rodriguez-Plata MT; Peña R; Blondeau C; Selwood DL; Izquierdo-Useros N; Moris A; Clotet B; Goulder P; Towers GJ; Prado JG
    J Virol; 2016 Oct; 90(19):8552-62. PubMed ID: 27440884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.